Terug

Watch Compare

Ascend Wellness Holdings, Inc.

Datakwaliteit: 100%

AAWH

OTC Manufacturing Chemicals

€ 0,48

▲ € 0,04 (9,59%)

Marktkapitalisatie: 97,09 M

Prijs

€ 0,48

Marktkapitalisatie

97,09 M

Dagbereik

€ 0,44 — € 0,47

52-Weeksbereik

€ 0,26 — € 1,20

Volume

103.146

Openen € 0,47

50D / 200D Gem.

€ 0,54

10,88% below

50D / 200D Gem.

€ 0,60

20,19% below

Quick Summary

Belangrijkste Punten

Revenue grew 10,78% annually over 5 years — strong growth

Generating 12,04 M in free cash flow

Revenue growth is decelerating — 1Y growth trails 5Y average by 21,65%

Capital efficient — spends only 5,20% of revenue on capex

Groei

Revenue Growth (5Y)

10,78%

Boven sectorgemiddelde (1,82%)

Revenue (1Y)-10,87%

Earnings (1Y)N/A

FCF Growth (3Y)-51,44%

Kwaliteit

Return on Equity

-812,71%

Onder sectorgemiddelde (-53,41%)

ROIC-1,67%

Net Margin-23,61%

Op. Margin-3,40%

Veiligheid

Debt / Equity

N/A

Current Ratio2,18

Interest Coverage-0,33

Waardering

PE (TTM)

-0,82

Boven sectorgemiddelde (-1,48)

P/B Ratio55,32

EV/EBITDA0,17

Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)

Metriek	Aandeel	Sector Mediaan
P/E	-0,8	-1,5
P/B	55,3	1,6
ROE %	-812,7	-53,4
Net Margin %	-23,6	-41,5
Rev Growth 5Y %	10,8	1,8
D/E	—	0,3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-10,87%	Revenue Growth (3Y)	-1,75%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	10,78%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	500,58 M	Net Income (TTM)	-118,19 M
ROE	-812,71%	ROA	-13,10%
Gross Margin	33,90%	Operating Margin	-3,40%
Net Margin	-23,61%	Free Cash Flow (TTM)	12,04 M
ROIC	-1,67%	FCF Growth (3Y)	-51,44%
Safety
Debt / Equity	N/A	Current Ratio	2,18
Interest Coverage	-0,33	Asset Turnover	0,55
Working Capital	113,21 M	Tangible Book Value	-262,89 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0,82	Forward P/E	N/A
P/B Ratio	55,32	P/S Ratio	0,19
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	0,17	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	12,41%
Market Cap	97,09 M	Enterprise Value	9,82 M
Per Share
EPS (Diluted TTM)	-0,58	Revenue / Share	2,47
FCF / Share	0,06	OCF / Share	0,19
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	5,20%	FCF Conversion	-10,19%
SBC-Adj. FCF	10,29 M	Growth Momentum	-21,65

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	500,58 M	561,60 M	518,59 M	405,93 M	332,38 M
Net Income	-118,19 M	-84,99 M	-48,21 M	-80,90 M	-122,66 M
EPS (Diluted)	-0,58	-0,40	-0,24	-0,44	-0,82
Gross Profit	169,68 M	184,21 M	155,12 M	134,56 M	135,97 M
Operating Income	-17,01 M	4,73 M	-3,62 M	-7,53 M	-17,20 M
EBITDA	—	—	—	—	—
R&D Expenses	—	—	—	—	—
SG&A Expenses	—	—	—	—	—
D&A	73,53 M	66,16 M	58,98 M	37,11 M	22,22 M
Interest Expense	51,29 M	45,26 M	36,98 M	32,44 M	63,99 M
Income Tax	51,38 M	45,17 M	33,45 M	41,69 M	41,72 M

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	907,93 M	900,43 M	919,55 M	872,16 M	723,44 M
Total Liabilities	954,55 M	828,63 M	776,68 M	708,75 M	546,96 M
Shareholders' Equity	-47,44 M	70,98 M	142,87 M	163,42 M	176,48 M
Total Debt	319,52 M	—	—	—	230,85 M
Cash & Equivalents	85,68 M	88,25 M	72,51 M	74,15 M	155,48 M
Current Assets	208,95 M	229,38 M	228,86 M	198,74 M	258,01 M
Current Liabilities	109,01 M	144,54 M	92,69 M	110,95 M	117,40 M